Enter your work email to finish reading GLP Boom: Explained Bringing a GLP-1 product to market means navigating pharma-level compliance, supply constraints, and shifting regulator expectations
Several other manufacturers have clinical trials in progress for potential competitors
To account for variations in comorbidities among patients, we utilized 3 comorbidity indices: the revised Charlson Comorbidity Index (CCI), the Chronic Disease Score (CDS), and the Elixhauser Index
By promoting weight loss, GLP-1 medications could help address both metabolic health and the associated inflammation simultaneously
There are also concerns about nutritional deficiencies , as the restrictive nature of keto combined with reduced appetite may result in inadequate intake of essential nutrients, fibre, and micronutrients
Many insurance plans cover Wegovy for weight loss for patients who meet the criteria, but coverage may vary within each insurance plan, so it is important to check with your provider